Retreatment of Patients Nonresponsive to Pegylated Interferon and Ribavirin with Daily High-Dose Consensus Interferon

Background. Current treatment of chronic hepatitis C with pegylated interferon and ribavirin has the ability to eliminate viral infection in about half of the patients treated. Therapeutic options, for those with remaining chronic hepatitis, will remain limited until novel antivirals become availabl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Meyer, Douglas F., Tobias, Hillel, Min, Albert D., Rajendra, Arathi, Zic, Ivanka, Brettholz, Edward, Clain, David J., Klion, Franklin, Bernstein, David, Bodenheimer, Henry C.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2010
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3003973/
https://ncbi.nlm.nih.gov/pubmed/21188197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/537827
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados